By analyzing transcriptome sequencings for MCF-7 cells treated with metformin and METTL3 knockdown SUM-1315 cells, we found that p21 might be the main target of METTL3 in breast cancer proliferation inhibitory effect of metformin. Here, CDKN1A is linked to breast carcinoma.